We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Latest Generation Acoustic Biosensors Launched in Europe

By LabMedica International staff writers
Posted on 05 Oct 2011
The latest addition to a line of acoustic biosensors is now available for purchase by European biotech researchers and other life scientists.

Acoustic biosensors do not require complex labeling methods; they are real-time analytical systems rather than equilibrium and can be used to investigate living cells rather than fixed cells or purified proteins. More...
A leader in the field of acoustic biosensors, SAW Instruments GmbH (Bonn, Germany), recently unveiled the samX, the latest high-end addition to the sam range of acoustic biosensors. The samX features eight analysis channels and adaptable routing that expands the workflow options available for increased power and flexibility.

The new system uses SAW’s proven proprietary surface acoustic wave technology to detect mass binding and protein conformational changes on whole cells. Surface acoustic wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analyzed. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

The new samX has two sensor chips for higher-end users, rather than the single chip of existing sam5 models, increasing the number of channels to eight, further facilitating the parallel processing of samples. In addition, different ligands can now be immobilized on-line at each chip position automatically, without the need for time-consuming, off-line protein loading.

Dr Markus Perpeet, managing director of SAW, said, “We are very excited to introduce users to the samX, which further extends the flexibility offered by our range of biosensors. The new system facilitates more complex assay design and can be easily adapted to meet the needs of each user, while increasing throughput speed and accuracy. It is particularly well suited to providing binding constants and kinetics data for ligands binding to membrane targets on cells, while results are obtained significantly faster than those from equilibrium-based methods.”

Related Links:
SAW Instruments GmbH



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.